Kumquat Biosciences Inc.
Clinical trials sponsored by Kumquat Biosciences Inc., explained in plain language.
-
New pill targets 'Undruggable' cancer mutation in first human test
Disease control Recruiting nowThis is a first-in-human study to test the safety and early effectiveness of an experimental oral drug called KQB548. It is for adults with advanced pancreatic, colorectal, or lung cancers that have a specific genetic change called KRAS G12D and have stopped responding to standar…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New cancer drug enters human testing: could it shrink tough tumors?
Disease control Recruiting nowThis is the first study in people testing KQB168, a new cancer drug, for adults with advanced solid tumors that have stopped responding to standard treatments. Researchers want to find the safest dose of KQB168 when taken alone or combined with another cancer drug (pembrolizumab)…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New cancer drug enters first human trials for advanced solid tumors
Disease control Recruiting nowThis early-stage study is testing a new cancer drug called KQB198 in adults with advanced solid tumors that have spread or cannot be surgically removed. Researchers want to find the safest dose of KQB198 when taken alone or combined with other cancer drugs, and see if it helps sh…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC